FILE - A woman holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on March 1, 2024. (AP Photo/Amanda Andrade-Rhoades, File) More U.S. adults believe it is a ...
Oruka Therapeutics is developing extended half-life monoclonal antibodies targeting IL-23p19 [ORKA-001] and IL-17A/F [ORKA-002] for autoimmune diseases. ORKA-001 aims for once-yearly dosing in ...
More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback